The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Levalbuterol
Levalbuterol · LEVALBUTEROL HYDROCHLORIDE 1.25 mg/3mL · Solution · Respiratory (Inhalation) · Aurobindo Pharma Limited
NDC 65862-0945-25 · 5 POUCH in 1 CARTON / 5 VIAL, SINGLE-DOSE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for levalbuterol (other) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market · price up 1% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA207625
- TE code
- AN
- Approval date
- Dec 30, 2016
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Levalbuterol (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurobindo Pharma Limited | LEVALBUTEROL HYDROCHLORIDE 1.25 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | LEVALBUTEROL HYDROCHLORIDE .31 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | LEVALBUTEROL HYDROCHLORIDE .63 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | LEVALBUTEROL HYDROCHLORIDE .31 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | LEVALBUTEROL HYDROCHLORIDE 1.25 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | LEVALBUTEROL HYDROCHLORIDE .63 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | LEVALBUTEROL HYDROCHLORIDE .63 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | LEVALBUTEROL HYDROCHLORIDE .31 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | LEVALBUTEROL HYDROCHLORIDE 1.25 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | LEVALBUTEROL HYDROCHLORIDE .63 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | LEVALBUTEROL HYDROCHLORIDE .31 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | LEVALBUTEROL HYDROCHLORIDE 1.25 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | LEVALBUTEROL HYDROCHLORIDE .63 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Levalbuterol — NDC 65862-0945-25," retrieved September 3, 2026, https://drugdashboards.com/drug/65862094525.
Free to cite with attribution — see how the data is put together.